Assessment of joint space narrowing with conventional standing antero-posterior radiographs: relief in mild-to-moderate pain is not a confounder in recent osteoarthritis structure-modifying drug trials
Rovati, L. C.; Pavelka, K.; Giacovelli, G.et al.
2006 • In Osteoarthritis and Cartilage, 14 (Suppl. A), p. 14-A18
osteoarthritis; glucosamine sulfate; radiographic measurement; joint space width
Abstract :
[en] Objective: Knee pain relief has been suggested to potentially alter radioanatomic positioning in conventional standing antero-posterior knee radiographs. This study was performed to determine whether this is always the case and in particular if it applied to two recent randomised, placebo-controlled trials showing both symptom- and structure-modification with glucosamine sulfate in knee osteoarthritis. Design: Patients in the two studies were selected if they completed the 3-year evaluations and, irrespectively of treatment, (1) were pain-improvers in that they underwent Western Ontario and McMaster Universities (WOMAC) osteoarthritis index (WOMAC) pain decrease at least equal to the mean improvement observed with glucosamine sulfate, or (2) if their baseline standing knee pain (item #5 of the WOMAC pain scale) was "severe" or "extreme" and improved by any degree at the end of the trials. Changes in minimum joint space width were then compared between treatments. Results: Knee pain was of mild-to-moderate severity in the two original studies and in all patient subsets identified here. Obviously, there were more pain-improvers in the glucosamine sulfate than in the placebo subsets (N 76 vs 57 in pooling the two studies), but WOMAC pain scores improved to the same extent (over 50% relative to baseline). Notwithstanding such a major pain relief, patients in the placebo subsets of both studies suffered a definite mean (SE) joint space narrowing, that was of -0.22 (0.15) mm in the pooled analysis, and that was not observed with glucosamine sulfate: +0.15 (0.07) mm; P= 0.003. Similar evidence was found in the smaller subsets with at least severe baseline standing knee pain improving after 3 years. Conclusions: Knee pain relief did not bias the report of a structure-modifying effect of glucosamine sulfate in two recent long-term trials, possibly due to the mild-to-moderate patient characteristics. Consensus deliverables should acknowledge that the potential limitations of conventional standing antero-posterior radiographs should not be overestimated since they may not apply to all patient populations and to all studies using this gold standard technique. (C) 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Disciplines :
General & internal medicine Orthopedics, rehabilitation & sports medicine
Author, co-author :
Rovati, L. C.
Pavelka, K.
Giacovelli, G.
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique
Language :
English
Title :
Assessment of joint space narrowing with conventional standing antero-posterior radiographs: relief in mild-to-moderate pain is not a confounder in recent osteoarthritis structure-modifying drug trials
Dougados M., and for the Group for the Respect of Ethics and Excellence in Science. Recommendations for the registration of drugs used in the treatment of osteoarthritis. Ann Rheum Dis 55 (1996) 552-557
Altman R., Brandt K., Hochberg M., and Moskowitz R. Design and conduct of clinical trials of patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Osteoarthritis Cartilage 4 (1996) 217-243
Committee for Proprietary Medicinal Products. Points to consider on clinical investigation of medicinal products used in the treatment of osteoarthritis. The European Agency for the Evaluation of Medicinal Products; July 1998.
Center for Drug Evaluation and Research. Clinical development programs for drugs, devices and biological products intended for the treatment of osteoarthritis. Food and Drug Administration (US); July 1999.
Buckland-Wright J.C., Scott Jr. W.W., and Peterfy C. Radiographic imaging techniques. Osteoarthritis Cartilage 4 (1996) 238-240
Buckland-Wright C. Radiographic assessment of osteoarthritis: comparison between existing methodologies. Osteoarthritis Cartilage 7 (1999) 430-433
Buckland-Wright J.C., Wolfe F., Ward R.J., Flowers N., and Hayne C. Substantial superiority of semiflexed (MTP) views in knee osteoarthritis: a comparative radiographic study, without fluoroscopy, of standing extended, semiflexed (MTP), and schuss views. J Rheumatol 26 (1999) 2664-2674
Mazzuca S.A., Brandt K.D., Dieppe P.A., Doherty M., Katz B.P., and Lane K.A. Effect of alignment of the medial tibial plateau and x-ray beam on apparent progression of osteoarthritis in the standing antero-posterior knee radiograph. Arthritis Rheum 44 (2001) 1786-1794
Brandt K.D., Mazzuca S.A., Conrozier T., Dacre J.E., Peterfy C.G., Provvedini D., et al. Which is the best radiographic protocol for a clinical trial of a structure modifying drug in patients with knee osteoarthritis?. J Rheumatol 29 (2002) 1308-1320
Neuhauser K.B., Anderson J.J., and Felson D.T. Rate of joint space narrowing in normal knees and knees with osteoarthritis. Arthritis Rheum 37 Suppl (1994) S423
Lethbridge-Cejku M., Hochberg M.C., Scott Jr. W.W., Plato C.C., and Tobin J.D. Longitudinal change in joint space of the knee: data from the Baltimore longitudinal study of aging. Arthritis Rheum 38 Suppl (1995) S262
Dieppe P.A., Cushnaghan J., and Shepstone L. The Bristol "OA500" Study: progression of osteoarthritis (OA) over 3 years and the relationship between clinical and radiographic changes at the knee joint. Osteoarthritis Cartilage 5 (1997) 87-97
Dieppe P., Cushnaghan J., Tucker M., Browning S., and Shepstone L. The Bristol "OA500 study": progression and impact of the disease after 8 years. Osteoarthritis Cartilage 8 (2000) 63-68
Reginster J.Y., Deroisy R., Rovati L.C., Lee R.L., Lejeune E., Bruyere O., et al. Long-term effects of glucosamine sulfate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 357 (2001) 251-256
Pavelka K., Gatterova J., Olejarova M., Machacek S., Giacovelli G., and Rovati L.C. Glucosamine sulfate use and delay of progression of knee osteoarthritis. Arch Intern Med 162 (2002) 2113-2123
Chard J., and Dieppe P. Update: treatment of osteoarthritis. Arthritis Rheum 47 (2002) 686-690
McAlindon T. Glucosamine for osteoarthritis: dawn of a new era?. Lancet 357 (2001) 247-248
Mazzuca S.A., Brandt K.D., Lane K.A., and Katz B.P. Knee pain reduces joint space width in conventional standing anteroposterior radiographs of osteoarthritic knees. Arthritis Rheum 46 (2002) 1223-1227
Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 29 (1986) 1039-1049
Lequesne M. Quantitative measurements of joint space width during progression of osteoarthritis: chondrometry. In: Kuetter K.E., and Goldberg V.M. (Eds). Osteoarthritic Disorders (1995), American Academy of Orthopedic Surgeons, Rosemont 427-444
Bellamy N., Buchanan W.W., Goldsmith C.H., Campbell J., and Stitt L.W. Validation of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15 (1988) 1833-1840
Ravaud P., Auleley G.-R., Chastang C., Rousselin B., Paolozzi L., Amor B., et al. Knee joint space width measurement: an experimental study of the influence of radiographic procedure and joint positioning. Br J Rheumatol 35 (1996) 761-766
Mazzuca S.A., Brandt K.D., and Katz B.P. Is conventional radiography suitable for evaluation of a disease-modifying drug in patients with knee osteoarthritis?. Osteoarthritis Cartilage 5 (1997) 217-226